|
|
Patient Fact Sheet Aquamid is a transparent, injectable gel for correction of soft tissue deficiencies and tissue augmentation. The sterile gel does not contain microparticles. Aquamid is produced by Ferrosan A/S, a Danish pharmaceutical company founded in 1920. Ferrosan A/S [via their subsidiary Aquamid has obtained full rights to manufacture, sell and market the gel internationally. This unique gel is:
Aquamid has been specially designed for correction of facial contour deformities due to ageing, acne, trauma, surgery and infection or due to congenital deformities, and can be used for:
Treatment should not be administered if there is infection of any type on the skin. Aquamid is unique due to its stability and long lasting cosmetic results. After the injection of Aquamid a thin layer of the body's own connective tissue surrounds the gel, enabling Aquamid to become a stable part in the connective tissue. Aquamid can be removed shortly after the injection if necessary. If the gel has to be removed at a later stage, a minor surgical procedure might be necessary, the success rate of which is variable. THE GEL ITSELF The Aquamid gel is homogeneous and does not contain any hard particles (microballs, microcrystals ). Aquamid effect is clearly linked to the volume injected, so the deeper the defect the more product will be required. Aquamid does not migrate; it is stable and inactive at the site of injection. Aquamid remains soft after injection and the implant is not distinguishable from the surrounding skin by palpation. The effect of the injection of Aquamid is permanent. Since the ageing of the skin continues, it may be necessary to carry out follow-up injections after a certain period of time, depending on a number of factors (skin structure, age, etc.) PAST USE Aquamid has been used for aesthetic correction for more than eight years. Retrospective studies have not shown any long-term side effects, clinically and histologically. SIDE EFFECTS Injection of Aquamid causes only mild reaction in the surrounding tissue which is minimal compared with reactions to other foreign bodies. This indicates that the gel is well tolerated by the human body. There is no calcification, no cancer causing effect, no inflammation and no local allergic reaction. The gel is not found in the lymph nodes. Aquamid does not cause any allergic reaction or any other immunological effect either in animals or in humans. Aquamid does not migrate. Adverse effects are seen in relation to 1-2% of injections mostly infection which is easily treated. Temporary reactions typically connected with injection may appear, for example reddening, pain, oedema, itching at the site of injection. Within 1 -2 weeks after treatment 1 out of 1500 patients have a risk of developjng transient swelling and tenderness near injection sites. If not caused by infection these reactions are self limiting and will resolve in a couple of weeks. AFTERCARE The patient should not expose the treated zone to intense heat (sun bed, sunbathing) or extreme cold in the first days following treatment. The purpose of this is to avoid inflammation of the zone where the injection has been made. The area should be kept clean and touching of the area avoided for the first few days after treatment. Any discomfort should respond to paracetamol. Should any problem arise it is important to contact the treating physician, as most problems are easy to fix if caught early. |